Latest news
Insmed's Explosive Quarter Reshapes the Debate: Momentum vs. Valuation - AD HOC NEWSAD HOC NEWS · Sun, 09 Aug 2026 16:12:16 GMTInsmed's Quarter Rewrites the Script, But the Charts Tell a More Complicated Story - AD HOC NEWSAD HOC NEWS · Sun, 09 Aug 2026 15:22:12 GMTInsmed's Growth Story Reaches an Inflection Point as BRINSUPRI Momentum Accelerates - AD HOC NEWSAD HOC NEWS · Sat, 08 Aug 2026 15:33:27 GMTInsmed's Pivot From Cash Burn to Cash Flow: What the 32% Weekly Surge Really Means - AD HOC NEWSAD HOC NEWS · Sat, 08 Aug 2026 15:03:23 GMTInsmed: BRINSUPRI Revenue Jumps 49% To $309 Million As Peak Sales Estimate Tops $7 Billion - Pulse 2.0Pulse 2.0 · Sat, 08 Aug 2026 00:35:06 GMTInsmed Raises Peak Sales Forecast Driven by Bronchiectasis Drug - sekbernews.idsekbernews.id · Fri, 07 Aug 2026 16:15:13 GMTWhat Insmed Stock’s Premium Is Actually Buying - TrefisTrefis · Fri, 07 Aug 2026 15:48:03 GMTInsmed Tops Q2 Earnings Estimates, Stock Soars 34% on Brinsupri Uptake - Zacks Investment ResearchZacks Investment Research · Fri, 07 Aug 2026 14:01:24 GMT